GENE ONLINE|News &
Opinion
Blog

2025-12-02|

Non-Contact Photothermal Method Introduced for Activating Frontal Polymerization in 3D Printing of Polymer Composites

by GOAI
Share To

Researchers have introduced a novel method in additive manufacturing that utilizes non-contact photothermal initiation to activate frontal polymerization during the 3D printing of polymer composites. This technique marks a significant development in materials science, enabling the creation of intricate polymer structures through an innovative approach. The method eliminates the need for direct contact during the initiation process, offering potential advancements in precision and efficiency within 3D printing technologies.

The research highlights how photothermal energy can initiate polymerization reactions remotely, allowing for controlled fabrication of complex designs. By leveraging this non-contact mechanism, scientists aim to enhance the versatility and scalability of 3D printing processes for polymer-based materials. The findings suggest potential applications across various industries requiring advanced manufacturing techniques for customized or intricate components. Further details on this advancement are available through ongoing studies and publications by the research team.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top